시장보고서
상품코드
1098618

말라리아 백신 시장 규모, 점유율, 전망, 기회(2022-2030년) : 병원체, 백신 종류, 유통 채널, 지역별

Malaria Vaccines Market, by Agent, by Vaccine Type, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

발행일: | 리서치사: Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

주요 기업은 계약 등의 성장 전략 채용에 주력하고 있으며, 예측기간 중 세계의 말라리아 백신 시장 성장을 촉진할 것으로 예측됩니다.

세계의 말라리아 백신(Malaria Vaccines) 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 대한 각종 영향요인 분석, 규제 상황, 파이프라인 분석, 시장 규모 추정과 예측, 각종 부문·지역/주요 국가별 내역, 경쟁 환경, 주요 기업 개요 등을 정리했습니다.

목차

제1장 조사 목적과 가정

제2장 시장 개요

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
  • 영향 분석
  • 규제 시나리오
  • 시장 동향
  • 파이프라인 분석
  • 주요 전개
  • 역학
  • PEST 분석
  • 제휴·인수
  • Porter's Five Forces 분석
  • 백신 개발 주기

제4장 세계의 말라리아 백신 시장 : COVID-19의 영향

  • 경제적 영향
  • 수요와 공급에 대한 영향
  • COVID-19 : 영향 평가

제5장 세계의 말라리아 백신 시장 : 병원체별

  • 열대열 말라리아 원충
  • 삼일열 말라리아 원충
  • 얼룩날개 모기류

제6장 세계의 말라리아 백신 시장 : 백신 종류별

  • 전 적혈구
  • 적혈구
  • 멀티 항원

제7장 세계의 말라리아 백신 시장 : 유통 채널별

  • 공공
  • 민간

제8장 세계의 말라리아 백신 시장 : 지역별

  • 북미
  • 라틴아메리카
  • 유럽
  • 아시아태평양
  • 중동
  • 아프리카

제9장 경쟁 상황

  • 히트맵 분석
  • 시장 점유율 분석
    • GlaxoSmithKline
    • Nobelpharma
    • Sanaria
    • CellFree Sciences
    • VLP Therapeutics LLC
    • Sumaya Biotech
    • BioNTech
    • Precigen, Inc

제10장 섹션

KSM 22.07.15

Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. It is preventable and curable. Malaria vaccines are used to prevent the spread of malaria. The only approved vaccine, as of 2021, is RTS,S, known by the brand name Mosquirix. In October 2021, the World Health Organization (WHO) for the first time recommended the large-scale use of a malaria vaccine for children living in areas with moderate-to-high malaria transmission. Four injections of malaria vaccines are required for full protection.

Market Dynamics

Key players operating in the global malaria vaccine market are focusing on adoption of growth strategies such as agreements which are expected to drive market growth during the forecast period. For instance, in January 2021, GlaxoSmithKline (GSK), a science-led global healthcare company, PATH (Program for Appropriate Technology in Health), nonprofit global health organization based in Seattle, U.S., and Bharat Biotech (BBIL), is an Indian multinational biotechnology company announced the signing of a product transfer agreement for the malaria vaccine, RTS,S/AS01E. The agreement includes, transfer of manufacturing of the RTS,S antigen part of the vaccine and the grant of a license on all rights pertaining to the RTS,S/AS01 malaria vaccine to BBIL. GSK will retain the production of the adjuvant of the vaccine (AS01E) and will supply it to BBIL. Moreover, increasing research and development for malaria vaccine is expected to propel the global malaria vaccine market over the forecast period. For instance, in April 2021, scientists at the University of Oxford's Jenner Institute announced that their Phase IIb trial of a candidate malaria vaccine achieved 77% efficacy in early stage trials - making it the first malaria vaccine to meet the WHO's target of 75%. The Phase IIb trial of the vaccine candidate, R21, enrolled 450 children in Burkina Faso, one of the 10 countries with the highest cases of malaria and subsequent deaths.

Key features of the study:

  • This report provides in-depth analysis of the global malaria vaccine market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Global Malaria vaccine Market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
  • Key companies covered as a part of this study include GlaxoSmithKline, Nobelpharma, Sanaria, CellFree Sciences, VLP Therapeutics LLC, Sumaya Biotech, BioNTech, and Precigen, Inc
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The Global Malaria vaccine Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global malaria vaccine market.

Detailed Segmentation:

  • Global Malaria vaccine Market, By Agent :
    • Plasmodium Falciparum
    • Plasmodium Vivax
    • Anopheles Species
  • Global Malaria vaccine Market, By Vaccine Type :
    • Pre-Erythrocytic
    • Erythrocytic
    • Multi-antigen
  • Global Malaria vaccine Market, By Distribution Channel :
    • Public
    • Private
  • Global Malaria vaccine Market, By Region:
    • North America
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Country
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Country
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • GlaxoSmithKline.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Nobelpharma
    • Sanaria
    • CellFree Sciences
    • VLP Therapeutics LLC
    • Sumaya Biotech
    • BioNTech
    • Precigen, Inc

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Agent
    • Market Snapshot, By Vaccine Type
    • Market Snapshot, By Distribution Channels
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunity
  • Impact Analysis
  • Regulatory Scenario
  • Market Trends
  • Pipeline Analysis
  • Key Developments
  • Epidemiology
  • PEST Analysis
  • Collaboration and Acquisition
  • Porters Analysis
  • Vaccine Developmental Cycle

4. Global Malaria Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic

  • Economic Impact
  • Impact on Demand and Supply
  • COVID-19 Impact Assessments

5. Global Malaria Vaccines Market, By Agent, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Plasmodium Falciparum
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Plasmodium Vivax
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Anopheles Species
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Malaria Vaccines Market, By Vaccine Type, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Pre-Erythrocytic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Erythrocytic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Multi-antigen
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

7. Global Malaria Vaccines Market, By Distribution Channel, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Public
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
  • Private
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

8. Global Malaria Vaccines Market, By Region, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Agent, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Agent, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Agent, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Agent, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Agent, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Agent, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017-2030,(US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • GlaxoSmithKline
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Nobelpharma
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Sanaria
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • CellFree Sciences
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • VLP Therapeutics LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Sumaya Biotech
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • BioNTech
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Precigen, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies

10. Section

  • Research Methodology
  • About us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제